← SynDRA
CERALASERTIB
SynDRA canonical compound SYN0039358 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | ATR |
| Mechanism of action | ATR kinase inhibitor |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- Atr kinase inhibitor azd6738
- Azd-6738
- AZD6738
- AZD 6738
- MFCD29472273
- BDBM50468001
- BDBM60432
- OHUHVTCQTUDPIJ-JYCIKRDWSA-N
- VJM
- CERALASERTIB [INN]
- Ceralasertib (AZD6738)
- CERALASERTIB [WHO-DD]
- Ceralasertib (JAN/USAN/INN)
- GTPL9390
- SCHEMBL9979340
- SCHEMBL29367507
- GLXC-90323
- EX-A1101
- AZD-6738?
- BDBM50585017
- NSC780249
- NSC800979
- s7693
- AKOS032960475
- CCG-268794
- CS-5187
- NSC-780249
- NSC-800979
- AC-32647
- FA145496
- HY-19323
- SY242122
- D11787
- Z3952965739
- imino-methyl-[1-[6-[(3R)-3-methylmorpholin-4-yl]-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl]cyclopropyl]-oxo-lambda6-sulfane
- E1044
- MFCD03790878
- 3-((2-Ethylhexyl)oxy)propane-1,2-diol
- ETHYLHEXYLGLYCERIN [MART.]
Look up CERALASERTIB in the interactive SynDRA portal →